HP Inc. heads into tonight's Q2 earnings report carrying a rare internal contradiction: the stock has surged 16.5% in a week, yet short sellers have barely flinched — and the Street's consensus is still firmly in the red.
The week's price action is striking. HPQ climbed from below $21 to $24.43, adding 23% over the past month and outpacing most of its hardware peers on the week. DELL led the group with a 28% weekly gain, but NTAP and HPE matched HPQ almost stride for stride at 15% apiece. The broad lift tells you this was largely a sector re-rating — trade-deal optimism and resilient enterprise spending data lifting the whole hardware cohort — rather than HPQ-specific alpha. The sharp 3.2% pullback on Tuesday, the day before earnings, is the counterweight: some of those gains are already being tested.
Short positioning has barely moved despite the rally. Short interest holds at 12.6% of free float — roughly 117 million shares — down less than 1% on the week and actually up 6.5% over the past month. That's a meaningful level. Bears have not run for cover even as the stock printed multi-month highs, which suggests conviction that the earnings event itself carries downside risk. The borrow market tells a different story on capacity: availability is wide at 299%, meaning there are nearly three shares available to lend for every one already borrowed. Cost to borrow is just 0.45% — barely above zero. Shorts are comfortable holding; the infrastructure to add more is there if needed. The ORTEX short score is 64.4, down modestly from a recent peak of 66 in mid-May, but still ranking in the 4th percentile — near maximum short pressure relative to the broader universe.
Options traders are leaning slightly defensive but not alarmed. The put/call ratio is 0.96, marginally above its 20-day average of 0.94, with a z-score close to zero. That's a long way from the hedged extremes seen in late April, when the PCR touched 1.13 amid the broader market selloff. Right now, options positioning is roughly balanced — not a flashing warning, but not a green light either.
The Street is a harder read. Morgan Stanley's Erik Woodring raised his price target to $17 just six days ago — still Underweight, and well below the current price of $24.43. That's a material gap. The consensus mean target across analysts is $19.68, implying roughly 19% downside from here if the post-rally level holds. Most of the notable target moves in recent months have been cuts: Goldman Sachs, Barclays, Wells Fargo, Citi, UBS and others all lowered their numbers after the February earnings print. The result is a uniform bearish tilt — no firm has upgraded to Buy in recent data. On valuation, the stock trades at a P/E of around 8.3x and EV/EBITDA near 6.7x, which ORTEX factor scores place in the 77th percentile for value. Momentum has been the laggard at just the 28th percentile, though notably that reading has climbed from a low of 20 in late April — a reflection of the past month's price recovery. Total stock score is 63.1, improving but not yet signalling broad-based quality improvement.
Recent earnings history offers a useful data point. The last four prints produced two small declines on day one (both under 0.8%) and one gain of 3.4% — with five-day moves consistently positive, ranging from 3.5% to 4.7%. The pattern suggests that once initial reactions settle, buyers have tended to emerge. Tonight's report arrives with HPQ already up 23% from its late-April lows, meaning the stock is priced with some expectations already embedded.
What to watch: whether management commentary on PC refresh demand and AI PC attach rates gives analysts reason to revisit a consensus that is almost uniformly positioned well below the current price — or validates it.
See the live data behind this article on ORTEX.
Open HPQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
